Home/Filings/4/0001166279-13-000001
4//SEC Filing

ARENA PHARMACEUTICALS INC 4

Accession 0001166279-13-000001

CIK 0001080709operating

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 8:34 PM ET

Size

13.0 KB

Accession

0001166279-13-000001

Insider Transaction Report

Form 4
Period: 2013-09-10
BEHAN DOMINIC P
DirectorSVP & Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2013-09-10$1.49/sh+150,000$223,500603,000 total
  • Exercise/Conversion

    Common Stock

    2013-09-10$1.81/sh+50,000$90,500653,000 total
  • Sale

    Common Stock

    2013-09-10$6.31/sh200,000$1,261,020453,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2013-09-10150,000150,000 total
    Exercise: $1.49Exp: 2021-03-15Common Stock (150,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2013-09-1050,000450,000 total
    Exercise: $1.81Exp: 2022-03-19Common Stock (50,000 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]This price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.26 and $6.34 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The options vest in four equal annual installments, and are exercisable once vested. The first and second installments became exercisable on March 15, 2012, and 2013, and the third and fourth installments vest on March 15, 2014, and 2015.
  • [F4]The options vest in four equal annual installments, and are exercisable once vested. The first installment became exercisable on March 19, 2013, and the second, third and fourth installments vest on March 19, 2014, 2015 and 2016.

Issuer

ARENA PHARMACEUTICALS INC

CIK 0001080709

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001080709

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 8:34 PM ET
Size
13.0 KB